Best PET-CT with Gallium 68 (DOTATATE) Doctors in Turkey — TOP 49

Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental. He integrates advanced PET-CT with Gallium 68 for staging gastrointestinal and neuroendocrine tumors.

• Trained at the University of Texas MD Anderson Cancer Center in the USA
• Completed a specialized oncology fellowship at the Hacettepe University Cancer Institute
• Expert in managing complex cancers using immunotherapy and targeted medical therapies
• Treats gastrointestinal, pancreatic, and thyroid cancers requiring precise diagnostic imaging
• Member of the oncology team at a JCI-accredited medical center in Istanbul

Professor Bulent Karagoz is a medical oncologist who specializes in neuroendocrine tumors. He treats these rare conditions at Anadolu Medical Center using PET-CT with Gallium 68 (DOTATATE) for precise staging.

• Former Head of Internal Medicine at Istanbul Okan University Faculty of Medicine
• Expert in neuroendocrine tumors and targeted therapies that attack specific cancer molecules
• Authored over 40 scientific publications focused on tumor biology and cancer research
• Member of the Turkish Medical Oncology Association and European Head and Neck Society
• Completed specialized training in tumor biology and ethical clinical research

Professor Kezban Berberoglu is a nuclear medicine specialist at Anadolu Medical Center. She completed advanced training in oncologic imaging at Johns Hopkins University School of Medicine.

• Specializes in PET-CT with Gallium 68 for neuroendocrine and prostate cancers
• Uses radioactive tracers to detect tumors and identify abnormal cell activity
• Professor at Istanbul Aydın University – one of Turkey's academic medical institutions
• Member of the European Association of Nuclear Medicine (EANM)
• Completed specialized courses in PET/CT and SPECT/CT imaging in the USA

Dr. Ilker Tinay leads urological oncology at Anadolu Medical Center. He uses Gallium 68 PSMA and DOTATATE PET-CT for precise cancer staging.

• Executive Board Member of the Association of Urooncology
• Fellow of the American College of Surgeons
• Specializes in biomarkers to identify specific urological cancer types
• Secretary of the Bladder Tumors Research Group
• Won the Scientific Research Award from the Urooncology Association

Professor Peker has performed over 400 pancreatic and gastric cancer surgeries. He specializes in the treatment of pancreatic neuroendocrine tumors at Hisar Hospital Intercontinental.

• Co-founded the Hepatopancreatobiliary Surgery unit at a major Turkish training hospital
• Performed 1,000 major operations including complex liver and biliary tract reconstructions
• Completed visiting surgery training at the Mayo Clinic in the USA
• Performs PET-CT with Gallium 68 (DOTATATE) to locate neuroendocrine tumors accurately
• Holds a PhD in Medical Biology focusing on cancer and stem cells

Dr. Tamer Aksoy is a nuclear medicine specialist at Hisar Hospital Intercontinental in Istanbul. He specializes in PET/CT examinations and radionuclide therapies. Dr. Aksoy completed clinical research as an observer at the Netherlands Cancer Institute in Amsterdam. He holds the title of Associate Professor.

• Member of the European Association of Nuclear Medicine.
• Expert in PET/CT imaging using Gallium 68 for precise diagnostics.
• Focuses on radionuclide therapy for oncology patients.
• Works at Hisar Hospital, which holds JCI accreditation for safety and quality.

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Dr. Sefik Igdem is a radiation oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating head, neck, and prostate cancers. He currently serves as a Professor at Demiroğlu Bilim University. Dr. Igdem uses Truebeam STx and Halcyon systems for accurate radiotherapy.

• Specializes in conformal treatments for complex tumor cases.
• Treats various conditions including lung, breast, and brain tumors.
• Practices at a JCI-accredited hospital that serves 200,000 patients annually.
• Completed his radiation oncology training at the Istanbul University Cerrahpaşa Faculty.

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center. He uses diagnostic results from Gallium 68 DOTATATE scans to plan cancer treatments.

• Trained at the Gülhane Military Medical Academy as an oncology expert
• Specializes in systemic therapies including immunotherapy and targeted therapy
• Focused on treating lung, liver, pancreatic, and urogenital cancers
• Member of the Turkish Medical Oncology Society
• Member of the Turkish Lung Cancer Society

Professor Aksoy is an Assistant Professor at Cerrahpaşa Medical Faculty. He leads specialized imaging and interventional radiology services at Hisar Hospital Intercontinental.

• Expert in PET-CT with Gallium 68 diagnostics at a high-volume medical center
• Resident-trained at Istanbul University Cerrahpaşa Medical Faculty – a top Turkish institution
• Specializes in interventional radiology using imaging guidance for minimally invasive procedures
• Member of the European Society of Radiology which sets high imaging standards
• Presented academic research at 13 national and international medical congresses

Dr. Rahib Hasanov is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a prestigious observership program at Houston Methodist Hospital in Texas. Dr. Hasanov specializes in personalized oncology using immunotherapy and targeted therapies. He treats a wide range of conditions including gastrointestinal, breast, and lung cancers.

• Expertise includes targeted therapies and novel agents for stage 4 cancers.
• Treats complex urogenital system tumors, including prostate and ovarian cancers.
• Practices at JCI-accredited Hisar Hospital, a center treating 250,000 patients annually.
• Member of the Turkish medical community with international training in the US.

Assoc. Prof. Dr. Heves Sürmeli is a specialist in Internal Medicine and Medical Oncology. She received her medical degree (M.D.) from Eskişehir Osmangazi University in 2004. She completed her Internal Medicine residency at Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul (2005–2010). She then completed subspecialty training in Medical Oncology at the same hospital (2014–2017).

At the same center, she served as a Medical Oncology Specialist (2017–2023). She then worked as Administrative and Clinical Director (2023–2026). Her clinical interests include breast, lung, gynecologic, gastrointestinal, and urologic cancers.

She has published many articles in international peer‑reviewed journals. She has presented at national and international conferences. She is active in professional societies. She has received several awards.

Professor Seref Komurcu is an ESMO-certified oncologist at Anadolu Medical Center. He specializes in treating neuroendocrine tumors that require PET-CT with Gallium 68 for staging.

• Authored over 110 scientific papers on cancer treatment
• Holds an ECFMG certificate from the United States
• Taught as a professor at Gulhane Military Medical Academy
• Treats neuroendocrine tumors of the pancreas and adrenal glands
• Member of the American Society of Clinical Oncology (ASCO)

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Dr. Sezer Saglam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating gastrointestinal and breast cancers. His research on rectal cancer timing has influenced global treatment protocols. Dr. Saglam develops personalized therapy plans using targeted medicine and precision techniques.

• Nominated for the International Best Researcher Award for work on liver cancer.
• Leads clinical trials focused on targeted therapies and precision oncology.
• Member of the American Society of Clinical Oncology (ASCO).
• Certified by the European Society for Medical Oncology (ESMO).

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Hasan Mutlu is a medical oncologist at Medical Park Antalya Hospital Complex. He specializes in immunotherapy, targeted cancer therapies, and genetic research in cancer treatment. Dr. Mutlu received his medical degree from Hacettepe University. He holds the title of Professor of Medicine. Dr. Mutlu focuses on organ tumor diagnosis and chemotherapy.

• Specializes in both medical and pediatric oncology cases.
• Treats complex conditions including neuroblastoma, Wilms tumor, and Ewing's sarcoma.
• Performs biological therapies and stays active in next-generation genetic research.
• Works at the Mediterranean region’s largest private hospital with PET-CT and LINAC technology.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.